Ativo Capital Management LLC Biogen Inc. Transaction History

Ativo Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $199,639 - $300,507	-845 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $2,586 - $3,425	-10 Reduced 1.17%	845 $226,000
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $229,866 - $291,589	855 New	855 $270,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1.32 Million - $1.46 Million	-6,042 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $559,545 - $875,194	2,582 Added 74.62%	6,042 $1.43 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.02 Million - $1.33 Million	3,460 New	3,460 $1.22 Million

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ativo Capital Management LLC with notifications on news.